• KLF4 Control of AgRP Isoforms in Mice

  2026-08-17

  This study identifies KLF4 as a positive transcriptional regulator of Agrp in mouse hypothalamic AgRP neurons and distinguishes the tissue-specific expression of three Agrp isoforms. Its conditional genetics, metabolic phenotyping, and GT1-7 cell experiments show that KLF4-dependent regulation increases energy expenditure in lean mice but is obscured during diet-induced obesity.

• Lipo3K Transfection Reagent for GBM Studies

  2026-08-17

  Build cleaner PXDN knockdown, LDHA rescue, and reporter workflows with a low-toxicity lipid transfection reagent. Lipo3K supports DNA, siRNA, mRNA, difficult cell models, and co-transfection designs without requiring routine medium replacement.

• Angiotensin I/II (1-5): RAS Workflow Guide

  2026-08-16

  Angiotensin I/II (1-5) supplies a defined Asp-Arg-Val-Tyr-Ile peptide fragment for controlled renin-angiotensin system research involving blood pressure regulation, vascular responses, and aldosterone release stimulation. It is suited to cardiovascular and renal physiology workflows, but its water insolubility, vehicle requirements, and limited product-specific evidence make it unsuitable as a general substitute for intact angiotensin peptides or unrelated signaling assays.

• RNA Pol II Inhibition and Apoptotic Signaling

  2026-08-15

  Harper et al. show that RNA polymerase II inhibition kills cells through an active apoptotic program rather than through passive loss of transcription, mRNA, or protein. Their functional-genomic and chemogenetic analyses define a Pol II degradation-dependent apoptotic response (PDAR) and suggest that this signaling mechanism contributes to the activity of diverse anticancer compounds.

• JZL184 Beyond MAGL: A Pain-Affect Assay Framework

  2026-08-14

  JZL184 is a selective monoacylglycerol lipase inhibitor for dissecting 2-AG, CB1, pain, and affective signaling. This guide presents an assay-centered framework that distinguishes enzyme, synaptic, sensory, and emotional endpoints.

• HyperFluor™ 488 Rabbit Anti-Goat IgG (H+L) Antibody

  2026-08-14

  Use this Alexa Fluor 488 conjugated secondary antibody to convert goat-primary immunoassays into sensitive, image-ready workflows across fluorescence microscopy, Western blotting, tissue staining, and flow cytometry. The article translates FXR-driven replication-organelle biology into practical assay design, controls, and troubleshooting decisions.

• iRhom2 Links Olfactory Receptors to Adaptation

  2026-08-13

  Azzopardi and colleagues identify iRhom2 as a distinctive component of olfactory sensory neurons and connect its expression with odorant receptor regulation and activity-dependent adaptation. Their combination of mouse genetics, transcriptomics, spatial analysis, and an ectopic receptor-signaling model supports an iRhom2/ADAM17 feedback mechanism, while also defining important limits on causal interpretation.

• Pazopanib Hydrochloride: Mechanism & Benchmarks

  2026-08-13

  Pazopanib Hydrochloride (GW786034) is a multi-target receptor tyrosine kinase inhibitor used in oncology research and approved clinical indications. This evidence-focused guide separates kinase potency, tumor-model activity, clinical scope, and viability-assay interpretation.

• Dasatinib and the SNAI1–EphA2 Translational Axis

  2026-08-12

  A translational framework for using Dasatinib (BMS-354825) to interrogate Src-linked signaling, EMT, stemness, and metastatic phenotypes emerging from the SNAI1–PIK3R2/p-EphA2 axis in thymic epithelial tumors.

• CA-074: A Selective Cathepsin B Inhibitor

  2026-08-12

  CA-074 enables mechanism-focused studies of cathepsin B in cancer metastasis, neurotoxicity, immune response modulation, and plant senescence. Its strong biochemical selectivity makes it useful for separating cathepsin B activity from broader cysteine-protease effects, provided assay context and cellular exposure are controlled.

• iRhom2 in Olfaction: Receptor Regulation and Adaptation

  2026-08-11

  Azzopardi and colleagues identify iRhom2 as a distinctive component of olfactory sensory neurons and connect its expression with odorant receptor regulation and activity-dependent adaptation. Their combination of knockout analysis, transcriptomics, spatial validation, and heterologous receptor signaling suggests that odor stimulation may engage an iRhom2–ADAM17 pathway that feeds back on olfactory gene expression.

• Reactive Oxygen Species Assay Kit (DHE)

  2026-08-11

  This scenario-driven guide explains how to design, optimize, and interpret live-cell intracellular superoxide measurements with Reactive Oxygen Species (ROS) Assay Kit (DHE), SKU K2066. It connects practical oxidative stress assay decisions with redox signaling and apoptosis research while distinguishing product specifications from workflow recommendations.

• Measuring Drug Response Beyond Viability

  2026-08-10

  Hannah Schwartz’s dissertation separates relative viability from fractional viability to clarify how cancer drugs inhibit proliferation and induce cell death. Its central implication is methodological: in vitro drug-response studies should treat growth suppression, killing, and response timing as related but nonidentical measurements.

• CHIR 99021 Trihydrochloride in Organoid Design

  2026-08-09

  CHIR 99021 trihydrochloride is a selective GSK-3 inhibitor for dissecting stem-cell state, Wnt-linked signaling, and glucose metabolism. This guide connects its molecular pharmacology with tunable intestinal organoid design and endpoint-aware assay planning.

• Resiquimod (R-848): From TLR Signals to Assays

  2026-08-08

  Resiquimod (R-848) is a dual TLR7/8 agonist that links innate immune response modulation with spatially controlled tumor-ablation research. This guide focuses on how to design, control, and interpret assays built around its timing, localization, and immune readouts.

15394 records 1/1027 page Next 12345 下5页 Last page